Kaushik Sarkar
About Kaushik Sarkar
Kaushik Sarkar is a Senior Scientist at Adaptimmune US, specializing in protein structure and biophysics. He has extensive experience in antibody discovery, structural biology, and protein chemistry, with a strong academic background including a Doctor of Philosophy from Dyson School of Design Engineering.
Current Role at Adaptimmune
Kaushik Sarkar serves as a Senior Scientist at Adaptimmune in Didcot, Oxfordshire, United Kingdom. He has held this position since 2019, contributing to the company's research and development efforts in the field of immunotherapy. His role involves applying his expertise in protein structure and biophysics to advance the understanding and application of T-cell therapies.
Previous Experience at UCB
Prior to his current role, Sarkar worked at UCB for several years in various capacities. He served as a Research Scientist in Structural Biology from 2010 to 2013, focusing on the structural aspects of biological molecules. He also held positions as a Research Scientist in Antibody Discovery and Engineering from 2013 to 2014, and as a Senior Scientist in Protein Structure and Biophysics from 2017 to 2019. His experience at UCB spanned a total of six years, where he developed significant expertise in protein chemistry and biophysics.
Educational Background
Sarkar has a strong academic background in science and engineering. He earned a Bachelor of Science degree from P.G. College of Law, Basheerbagh from 2002 to 2005. He then pursued a Master of Science at Nottingham University Business School from 2005 to 2006. Following this, he completed a Doctor of Philosophy at Dyson School of Design Engineering from 2014 to 2018, where he focused on advanced topics in engineering and design.
Early Career at UCB
Kaushik Sarkar began his career at UCB as an Industrial Placement in 2006 for a duration of three months. He then transitioned to a Research Associate role in Protein Chemistry, where he worked from 2006 to 2010. This early experience laid the foundation for his subsequent roles in structural biology and antibody engineering, contributing to his overall expertise in the field.